✦ LIBER ✦

P385 Population pharmacokinetic modelling of vedolizumab in patients with ulcerative colitis or Crohn's disease

✍ Scribed by Rosario, M.; Dirks, N.; Gastonguay, M.; Fox, I.; Milton, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1225 Population Pharmacokinetic Modeli

✍ Dirks, Nathanael L.; Rosario, Maria; Gastonguay, Marc R.; Fox, Irving; Milton, A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 124 KB

P130 AWARENESS OF CROHN'S DISEASE AND UL

✍ S. Angelberger; H. Vogelsang; G. Novacek; W. Miehsler; C. Dejaco; A. Gangl; W. R 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 59 KB

P459 Predominant dysbiosis in patients w

✍ K. Machiels; M. Joossens; J. Sabino; V. De Preter; I. Arijs; V. Ballet; K. Claes 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

No Increased Risk of Myocardial Infarcti

✍ Osterman, Mark T.; Yang, Yu–Xiao; Brensinger, Colleen; Forde, Kimberly A.; Licht 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Evaluation of serologic disease markers

✍ Dr. William J. Sandborn; Edward V. Loftus Jr; Jean Frederic Colombel; Kenneth A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Pharmacokinetics of a 5-aminosalicylic a

✍ B. NORLANDER; R. GOTTHARD; M. STRÖM 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB